Bloomberg Bristol-Myers Squibb Co. agreed to divest one of Celgene Corp.’s most lucrative drugs in order to close their planned $74 billion merger. Under an agreement with the Federal Trade Commission, Bristol-Myers will sell off the psoriasis pill Otezla to appease antitrust regulators’ concerns, the company said in a statement. Bristol- Myers shares fell 7.6 percent to $45.57 in New ...

Bloomberg Iran’s supreme leader scorned the idea of negotiations to ease his country’s tense standoff with the US in his first comments since being sanctioned by Donald Trump. “If we agree in negotiations to their demands, they will make the nation miserable,” Ayatollah Ali Khamenei said, arguing Washington was attempting to strip Iran of its economic and defense capabilities. “And ...

Bloomberg Ethiopian Prime Minister Abiy Ahmed vowed to press ahead with his reform agenda, saying he won’t be deterred by attacks on the country’s leadership. “We will learn from the obstacles to prevent it from happening again,” Abiy said in a statement posted on his office’s Twitter account. “We will not steer away from our reforms, not even for a ...